Venous Thromboembolism Treatment Market to reach USD 2.13 Bn by 2032 at a CAGR of 8.50%.
The venous thromboembolism treatment market is developing gradually. Various factors make this phenomenon occur: increased attention campaigns and technological progress. The Centers for Disease Control and Prevention provide information on the VTE issue in the United States.